These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7073149)

  • 1. Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen.
    Dienstag JL; Stevens CE; Bhan AK; Szmuness W
    Ann Intern Med; 1982 May; 96(5):575-9. PubMed ID: 7073149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
    Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
    Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers.
    Chu CM; Sheen IS; Lin SM; Liaw YF
    Clin Infect Dis; 1993 May; 16(5):709-13. PubMed ID: 8507764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan.
    Chen SM; Kung CM; Yang WJ; Wang HL
    J Clin Virol; 2011 Sep; 52(1):11-6. PubMed ID: 21767983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBsAG positive reactivity in man not due to hepatitis B virus.
    Coursaget P; Yvonnet B; Bourdil C; Mevelec MN; Adamowicz P; Barrès JL; Chotard J; N'Doye R; Diop Mar I; Chiron JP
    Lancet; 1987 Dec; 2(8572):1354-8. PubMed ID: 2446096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).
    Maupas P; Chiron JP; Barin F; Coursaget P; Goudeau A; Perrin J; Denis F; Mar ID
    Lancet; 1981 Feb; 1(8215):289-92. PubMed ID: 6109938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoprevention of hepatitis B in children].
    Kätzner K; Laufs R
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):124-5. PubMed ID: 6727883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccine: further studies in children with previously acquired hepatitis B surface antigenemia.
    Barin F; Yvonnet B; Goudeau A; Coursaget P; Chiron JP; Denis F; Mar ID
    Infect Immun; 1983 Jul; 41(1):83-7. PubMed ID: 6222991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.